Regular Article
Characterization of DNA-Binding Proteins Required for Glucocorticoid Induction of CYP3A23

https://doi.org/10.1006/abbi.1997.0467Get rights and content

Abstract

Cytochrome P450 (CYP) 3A23 is transcriptionally regulated in rat liver by such glucocorticoids as dexamethasone (DEX) and by such antiglucocorticoids as pregnenolone 16α-carbonitrile (PCN). Based on studies of CYP3A23 gene fragments expressed in primary cultures of adult rat hepatocytes and tested for DNA–protein interactions, we have proposed that the mechanism of CYP3A23 induction by these steroid hormones involves the glucocorticoid receptor or a protein induced by glucocorticoids indirectly interacting with proteins constitutively bound to an enhancer element consisting of a direct repeat of 7-bp separated by two nucleotides in the 5′-flanking region of the CYP3A23 gene (L. Quattrochiet al., J. Biol. Chem.270, 28917, 1995). In the present study, we prepared and transiently expressed in cultured rat hepatocytes 20-bp double-stranded (ds)-oligonucleotides containing this direct repeat or various mutations of this direct repeat inserted into a chloramphenicol acetyltransferase (CAT) reporter plasmid. We found that both repeats were necessary for induction of CAT by either DEX or PCN. Analysis of proteins bound to CYP3A23 enhancer through the use of uv cross-linking revealed two rat liver nuclear proteins with molecular masses of approximately 130 and 100 kDa, as well as several proteins of molecular masses between 45 and 60 kDa, that specifically bind to the 20-bp ds-oligonucleotide CYP3A23 enhancer. Methylation interference assays determined that all guanine residues within the direct repeats of this oligonucleotide are important for protein binding. Mutations of these guanine residues abolished binding of nuclear proteins and eliminated DEX or PCN inducibility of CAT. These data suggest that constitutively bound proteins, interacting with the CYP3A23 enhancer possibly as a heterodimeric complex, play a role in the glucocorticoid inducibility of CYP3A23.

References (36)

  • N.A. Elshourbagy et al.

    J. Biol. Chem.

    (1980)
  • E.G. Schuetz et al.

    J. Biol. Chem.

    (1984)
  • E.G. Schuetz et al.

    J. Biol. Chem.

    (1984)
  • L.C. Quattrochi et al.

    J. Biol. Chem.

    (1995)
  • D. Li et al.

    Methods Enzymol.

    (1991)
  • J.M. Graham et al.

    Anal. Biochem.

    (1990)
  • T. Osumi et al.

    Biochem. Biophys. Res. Commun.

    (1991)
  • K. Umesono et al.

    Cell

    (1991)
  • C. Jonat et al.

    Cell

    (1990)
  • M. Beato

    Cell

    (1989)
  • M.S. Denison et al.

    J. Biol. Chem.

    (1988)
  • D.M. Heuman et al.

    Mol. Pharmacol.

    (1982)
  • H-J. Burger et al.

    Proc. Natl. Acad. Sci. USA

    (1992)
  • G. Jiang et al.

    Mol. Cell. Biol.

    (1995)
  • M.J. Tsau et al.

    Annu. Rev. Biochem.

    (1994)
  • J.M. Huss et al.

    Proc. Natl. Acad. Sci. USA

    (1996)
  • H.K. Kleinman et al.

    Biochemistry

    (1985)
  • Cited by (16)

    • Orphan Receptor Promiscuity in the Induction of Cytochromes P450 by Xenobiotics

      2001, Journal of Biological Chemistry
      Citation Excerpt :

      Therefore, although some of the inhibitory effects of PXR may be due to competition with CAR for binding to RXRα, the majority most likely is due to competition with CAR for binding to the NR1 site of the PBRE. In response to PCN, PXR1 stimulates CYP3A1 gene expression by binding to a DR3 PXRE (5′-TGAACT TCA TGAACT-3′) (10, 13). The PXRE of CYP3A1 and the NR1 of the CYP2B1 PBRE were found to compete in gel mobility shift assays for binding to rat liver nuclear proteins (Fig.1 C).

    • Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: Analysis with a novel reverse transcriptase-polymerase chain reaction assay

      2000, Biochemical Pharmacology
      Citation Excerpt :

      The differential induction of CYP3A1 and CYP3A2 expression by dexamethasone reflects a remarkable difference in regulation of CYP3A1 and CYP3A2 transcription by glucocorticoids, despite their highly comparable promoter structure. The CYP3A1 and CYP3A2 promoters both contain HNF4-binding sites and two dexamethasone response elements, referred to as DexRE-1 and DexRE-2 [33–36]. The DR-3 sequence in DexRE-2, 5′-AGTTCAN3AGTTCA-3′, can be bound by a heterodimer of PXR and RXRα [37, 38].

    View all citing articles on Scopus

    Abbreviations used: CYP, cytochrome P450; DEX, dexamethasone; PCN, pregnenolone 16α-carbonitrile; CAT, chloramphenicol acetyltransferase; TK, thymidine kinase; GR, glucocorticoid receptor; RAR, retinoic acid receptor; RXR, retinoid X receptor; PPAR, peroxisome proliferator-activated receptor; TR, thyroid hormone receptor; VDR vitamin D receptor; DTT, dithiothreitol; RARE, RAR response element; RXRE, RXR response element; TRE, TR response element; VDRE, VDR response element; PPARE, PPAR response element

    1

    To whom correspondence should be addressed at UCHSC Medical Toxicology, B146, 4200 East 9th Avenue, Denver, CO 80262. Fax: (303) 315-7180.

    View full text